|
Clinical Trial Incontinence Overactive Bladder
|
|
1. Maastricht University Medical Center, Maastricht, Netherlands, 2. Pitie-Salpetrière Academic Hospital, Paris, France, 3. Hospital S. João and Faculty of Medicine of Porto, Porto, Portugal, 4. University of Toronto, Toronto, Canada, 5. Astellas Pharma Global Development, Northbrook, IL, USA, 6. Astellas Pharma Europe Ltd, Chertsey, Surrey, UK and Department of Urology, Ealing Hospital, London, UK
|